Brevan Howard Capital Management LP Grows Stock Position in Intuitive Surgical, Inc. $ISRG

Brevan Howard Capital Management LP raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 895.3% during the third quarter, Holdings Channel.com reports. The firm owned 10,988 shares of the medical equipment provider’s stock after purchasing an additional 9,884 shares during the period. Brevan Howard Capital Management LP’s holdings in Intuitive Surgical were worth $4,914,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the business. Rossmore Private Capital increased its position in shares of Intuitive Surgical by 2.0% during the 3rd quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock worth $446,000 after purchasing an additional 20 shares during the last quarter. Activest Wealth Management lifted its position in Intuitive Surgical by 21.7% in the third quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock valued at $50,000 after buying an additional 20 shares during the last quarter. Vertex Planning Partners LLC boosted its stake in Intuitive Surgical by 2.3% during the second quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock worth $498,000 after buying an additional 21 shares during the period. Accredited Investors Inc. boosted its stake in Intuitive Surgical by 2.0% during the third quarter. Accredited Investors Inc. now owns 1,060 shares of the medical equipment provider’s stock worth $474,000 after buying an additional 21 shares during the period. Finally, SPC Financial Inc. increased its position in shares of Intuitive Surgical by 1.3% during the third quarter. SPC Financial Inc. now owns 1,614 shares of the medical equipment provider’s stock valued at $722,000 after acquiring an additional 21 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: FDA clearance expands da Vinci 5 into cardiac surgery, opening a much larger long-term TAM (management cites a jump from ~17k to ~160k addressable procedures in cleared markets) — a multi-year growth driver for procedure volume and consumables. Read More.
• Positive Sentiment: Completed acquisition of Southern Europe distributor businesses (Italy, Spain, Portugal) shifts da Vinci and Ion sales to direct operations — should improve control of regional sales/service and capture margin/recurring revenue over time. Read More.
• Positive Sentiment: Sell-side momentum: Citigroup upgraded ISRG to Buy and several analysts maintain bullish price targets, supporting upside thesis and sentiment. Read More.
• Positive Sentiment: Recent Q4 results beat consensus (strong revenue and EPS growth), reinforcing recurring-consumables revenue and the upgrade cycle for da Vinci systems. Read More.
• Neutral Sentiment: Analyst consensus shows meaningful upside (Zacks highlights ~29.7% average target upside), but that depends on execution and multiple expansion remaining intact. Read More.
• Neutral Sentiment: Long-form bullish pieces reiterate a multi-year growth story from da Vinci 5, Ion and software/services but don’t change near-term valuation concerns. Read More.
• Negative Sentiment: Cybersecurity incident (phishing-linked breach affecting internal systems) is the immediate catalyst for the share decline — investors will watch for customer impact, data exposure, and remediation costs. Read More.
• Negative Sentiment: Insider selling (recent EVP share sales) and management guidance calling for a deceleration in worldwide da Vinci procedure growth in 2026 could pressure near-term sentiment and valuation. Read More. • Read More.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on ISRG shares. Citigroup raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target on the stock in a research note on Wednesday, March 11th. Wells Fargo & Company boosted their target price on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research report on Friday, December 12th. Raymond James Financial upped their price target on Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. Robert W. Baird lowered their price target on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research report on Friday, January 23rd. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and issued a $714.00 price objective on shares of Intuitive Surgical in a research note on Friday, January 9th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $615.86.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Myriam Curet sold 105 shares of the company’s stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total transaction of $51,864.75. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Mark Brosius sold 645 shares of the stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $485.01, for a total value of $312,831.45. Following the completion of the sale, the senior vice president directly owned 1,613 shares in the company, valued at $782,321.13. This represents a 28.57% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 32,943 shares of company stock valued at $17,279,568 in the last three months. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Stock Down 1.5%

Shares of ISRG opened at $472.16 on Monday. The company has a market cap of $167.68 billion, a P/E ratio of 59.84, a PEG ratio of 3.64 and a beta of 1.66. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The firm’s 50 day moving average price is $513.26 and its 200 day moving average price is $512.96.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating the consensus estimate of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm’s revenue was up 18.8% compared to the same quarter last year. During the same quarter last year, the company posted $2.21 EPS. Research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.